IL-17 antibody formulation and method of treatment using same
The present invention provides stabilized pharmaceutical formulations for anti-IL-17 antibodies, comprising e.g. citrate, sodium chloride and polysorbate-80 at pH 5.7. These stabilized anti-IL-17 antibody pharmaceutical formulations can be used to treat rheumatoid arthritis, psoriasis, ankylosing sp...
Saved in:
Main Authors | , , , |
---|---|
Format | Patent |
Language | English |
Published |
28.06.2016
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The present invention provides stabilized pharmaceutical formulations for anti-IL-17 antibodies, comprising e.g. citrate, sodium chloride and polysorbate-80 at pH 5.7. These stabilized anti-IL-17 antibody pharmaceutical formulations can be used to treat rheumatoid arthritis, psoriasis, ankylosing spondilitis, psoriatic arthritis or multiple myeloma. |
---|---|
Bibliography: | Application Number: US201314379755 |